Northwest Biotherapeutics Overview

  • Founded
  • 1996

Founded
  • Status
  • Public

  • Employees
  • 20

Employees
  • Stock Symbol
  • NWBO

Stock Symbol
  • Investments
  • 2

  • Share Price
  • $0.73

  • (As of Tuesday Closing)

Northwest Biotherapeutics General Information

Description

Northwest Biotherapeutics Inc is a biotechnology company involved in the development of cancer vaccines. The target is a broad range of solid-tumor cancers. The company has a proprietary manufacturing technology, which it uses to produce a personalized vaccine. The product portfolio includes product candidates such as DCVax-L, for patients with brain cancer; DCVax-Direct, direct injection into all types of inoperable solid tumor cancers, and DCVax for late-stage ovarian cancer. DCVax-Prostate, for late-stage prostate cancer, has received clearance from the U.S. Food and Drug Administration.

Contact Information

Website
www.nwbio.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Primary Office
  • 4800 Montgomery Lane
  • Suite 800
  • Bethesda, MD 20814
  • United States
+1 (240) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Northwest Biotherapeutics Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.73 $0.74 $0.39 - $2.05 $779M 1.05B 3.04M $0.08

Northwest Biotherapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 767,103 671,624 1,130,425 144,890
Revenue 1,086 1,005 1,291 2,410
EBITDA 63,844 184,723 (520,852) (17,837)
Net Income 56,586 179,126 (529,821) (20,812)
Total Assets 31,098 40,160 32,899 10,643
Total Debt 30,575 37,938 19,857 18,032
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Northwest Biotherapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Northwest Biotherapeutics‘s full profile, request access.

Request a free trial

Northwest Biotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Northwest Biotherapeutics Inc is a biotechnology company involved in the development of cancer vaccines. The target is a
Drug Discovery
Bethesda, MD
20 As of 2021
00000
000000000 - 00000

000000

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
0000000000000
San Diego, CA
000 As of 0000
00000
000000000 - 00000

000 00

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volu
0000 000000000
Epalinges, Switzerland
000 As of 0000
00.000
0.000 0000-00-00
00000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Northwest Biotherapeutics Competitors (52)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sorrento Therapeutics Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
000 000000000000 Formerly VC-backed Epalinges, Switzerland 000 00.000 00000000 00.000
00000000 00000000 Corporation Boston, MA 0 000 000000000 000
0000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
000000 Formerly VC-backed Bothell, WA 0000 00.000 000000&0
You’re viewing 5 of 52 competitors. Get the full list »

Northwest Biotherapeutics Executive Team (8)

Name Title Board Seat Contact Info
Marnix Bosch Ph.D Chief Technology Officer
Alton Boynton Ph.D Chief Scientific Officer & Founder
Les Goldman Senior Vice President, Business Development
Linda Powers JD Chief Executive Officer & Chief Financial Officer, Finance
You’re viewing 4 of 8 executive team members. Get the full list »

Northwest Biotherapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Northwest Biotherapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Northwest Biotherapeutics‘s full profile, request access.

Request a free trial

Northwest Biotherapeutics Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 28-Aug-2020 0000000000 00.00 Other Devices and Supplies 00000 000
MithraGen 01-Jan-2008 Merger/Acquisition Biotechnology
To view Northwest Biotherapeutics’s complete acquisitions history, request access »

Northwest Biotherapeutics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Northwest Biotherapeutics’s complete esg history, request access »